Skip to content

Features Emotional Responses in Adults With Autism: Comparison With Bipolar Disorder (REMBAU)

Features Emotional Responses in Adults With Autism: Comparison With Bipolar Disorder

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02423499
Acronym
REMBAU
Enrollment
90
Registered
2015-04-22
Start date
2015-05-19
Completion date
2021-05-26
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorder, Bipolar Disorder

Keywords

Autism Spectrum Disorder, Bipolar Disorder, Emotions

Brief summary

The objective of this study is to identify the specific characteristics of Autism Spectrum Disorder (ASD) in emotional response profiles and shared with Bipolar Disorder (BD) characteristics.

Interventions

None listed

Sponsors

University Hospital, Tours
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* For all participants: * Age between 18 and 50 years * Normal vision (or corrected) * Absence of neurological disorder (epilepsy , head trauma, ... ) * Ability to understand information about the protocol * Informed and signed consent * normal mood (euthymia) * normal or high intelligence * Subjects with ASD: * Subjects with an autism spectrum disorder according to the DSM-5 * The diagnosis is confirmed by diagnostic interviews: ADI- R (Autism Diagnostic Interview-Revised) and / or ADOS (Autism Diagnostic Observation Schedule ) . * Subjects with bipolar disorder: * Diagnosis of bipolar disorder according to DSM-IV-TR or DSM -5 * The diagnosis is confirmed by the MINI 6.0 (The Mini-International Neuropsychiatric Interview) . * Healthy volunteers: * Inclusion after checking the national register of healthy volunteers * No history of disease of the central nervous system or psychiatric disorder * No family history of ASD or BD in the first degree * Lack of psychotropic medication or current cardiotropic * Lack of psychiatric disorder on Axis I MINI 6.0 * AQ Score \< 32

Design outcomes

Primary

MeasureTime frame
Physiological emotional response during emotion elicitation in a laboratory session (Pupil size measured by eye tracking, heart rate, electrodermal response, breath rate) during emotion elicitation in a laboratory sessionaverage 1 hour

Secondary

MeasureTime frame
Subjective emotional response during emotion elicitation in a laboratory sessionaverage 1 hour
Facial emotional response during emotion elicitation in a laboratory sessionaverage 1 hour
Experience sampling method in real life during a week (emotions, activities, social context, burden)within the first 7 days after inclusion
Physiological emotional response in real life (heart rate, electrodermal response, breath rate, actimetry)within the first 24h approx. after inclusion

Countries

France

Contacts

PRINCIPAL_INVESTIGATORFrédérique BONNET- BRILHAULT, Pr

University Center of Child and Adolescent Psychiatry, University Hospital of Tours

PRINCIPAL_INVESTIGATORWissam EL-HAGE, Pr

University Psychiatric Clinic, University Hospital of Tours

PRINCIPAL_INVESTIGATORValérie GISSOT, MD-PHD

Clinical Investigation Center, INSERM 14 15, University Hospital of Tours

STUDY_DIRECTORMathieu LEMAIRE, MD-PHD

University Center of Child and Adolescent Psychiatry, University Hospital of Tours

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 16, 2026